VERA IMPERIALE: Open Payments
NPI 1699890095 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,821 in 178 payments from 16 companies in 2025. Trend: 2023 $9,995 · 2024 $14,935 · 2025 $11,821
Honoraria: $5,750Food & beverage: $4,866Travel & lodging: $1,205
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 18 | $7,731 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $862 |
| Alkermes, Inc. | 16 | $465 |
| ABBVIE INC. | 16 | $410 |
| Neurocrine BioSciences, Inc. | 16 | $395 |
| Janssen Pharmaceuticals, Inc | 15 | $355 |
| Vanda Pharmaceuticals Inc. | 16 | $300 |
| Teva Pharmaceuticals USA, Inc. | 9 | $273 |
| E.R. Squibb & Sons, L.L.C. | 10 | $208 |
| Axsome Therapeutics, Inc. | 7 | $177 |
Products named: Qelbree, CAPLYTA, VRAYLAR, INGREZZA, LYBALVI, FANAPT, REXULTI, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
